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Objective. This paper reports the findings comparing the obstetrical health, antenatal care, and psychosocial characteristics of
pregnant women with a known history of substance dependence (n = 41) and a comparison group of pregnant women attending
a general antenatal clinic (n = 47). Method. Face-to-face interviews were used to assess obstetrical health, antenatal care, physical
and mental functioning, substance use, and exposure to violence. Results. The substance-dependent group had more diﬃculty
accessing antenatal care and reported more obstetrical health complications during pregnancy. Women in the substance-dependent
group were more likely to report not wanting to become pregnant and were less likely to report using birth control at the time of
conception. Conclusions. The profile of pregnant women (in specialised antenatal care for substance dependence) is one of severe
disadvantage and poor health. The challenge is to develop and resource innovative and eﬀective multisectoral systems to educate
women and provide eﬀective care for both women and infants.
1. Introduction
There has been a wealth of literature examining the impact
of substance use in pregnancy with findings consistently
noting the association between maternal substance use and
negative fetal outcomes including fetal respiratory distress,
preterm delivery, small-for-gestational-age birth, and higher
infant mortality in the first year of life [1–4]. Moreover,
this association is complicated by the significant physical
and psychosocial morbidity associated with substance use
disorders. Studies have previously found high exposure to
violence, poor physical health, and moderate/severe psy-
chological distress among substance-using pregnant women
[5–7]. It is often argued that integrated service delivery
and intensive case management is needed to ensure the
well-being of the mother-infant dyad throughout pregnancy
and into the longer term.
The health care system in Australia is largely divided into
specialist streams and segregated levels of care. Such a system
is often criticized for being too divisive and inadequate for
the wholistic care of patients who present with multiple
problems [8, 9]. In New South Wales, diﬀerent models of in-
tegrated care for substance-using pregnant women exist. This
includes perinatal consultation and liaison services operated
from drug and alcohol treatment centres and multidisciplin-
ary teams situated within antenatal clinics.
This paper reports on a specialist antenatal clinic of a
large public hospital in Sydney, where a collaborative ap-
proach to the care of pregnant women with known sub-
stance use problems has been adopted. The specialist clinic
is conducted weekly from the Maternal and Child Health
Department and is convened by staﬀ from a number of dif-
ferent departments including Obstetrics and Gyneacology,
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Maternal and Child Health, Drug Health, and Social Work.
The objective of the specialist clinic is to address the myriad
of physical and psychosocial problems that substance using
pregnant women present with in order to improve maternal
and infant outcomes for the duration of the pregnancy and
into the postpartum period. Referral to the specialist ante-
natal clinic can occur via a number of pathways including
community-based general practitioners, the Drug Health
Service, the Aboriginal Medical Service, and women attend-
ing other antenatal clinics who screen positive for substance
use (all women are assessed for substance use, domestic
violence exposure, nutritional status, and depression using a
standardised psychosocial screening tool at their first booked
appointment regardless of the antenatal clinic they attend).
The aim of the present study was to describe the clinical
and psychosocial characteristics of pregnant women attend-
ing the specialist substance use antenatal clinic of a large pub-
lic hospital in Sydney, Australia, and to compare these to the
characteristics of a group of women attending a generalist
antenatal clinic. This information was collected as a prereq-
uisite to the design of a clinical service that could better meet
the needs of both mother and child.
2. Materials and Method
The present study is a retrospective, cross-sectional study
examining the characteristics of women with a known his-
tory of substance dependence accessing antenatal care from
a clinic of a large public hospital in Sydney, Australia. A
specialist clinic for women with substance use problems is
run in conjunction with the general antenatal clinic and
provides additional support around substance use and as-
sociated psychosocial issues. Women with a known history
of substance use were approached to participate by the
Drug Health Service Perinatal Clinical Nurse Consultant. All
women attending the general antenatal clinic or birth centre
of the same hospital were eligible to participate in the com-
parison group. Women in the comparison group were either
invited to participate by a researcher while waiting for an
appointment, or responded to advertisements posted in the
clinic waiting room. Face-to-face interviews were conducted
by researchers trained to administer structured clinical
interviews, at either the antenatal clinic or the National Drug
and Alcohol Research Centre, and took on average 1 hour to
complete. All women provided written consent prior to par-
ticipating. While no women were screened and deemed to be
ineligible, a number of women declined to participate with
the majority citing they were too busy or had too many other
things going on. As such, it took approximately 18 months of
recruitment to achieve the sample size reported. The study
was approved by the University of New South Wales Human
Research Ethics Committee (ref: 06254 and 08224) and the
Ethics Review Committee (RPAH Zone) of the Sydney South
West Area Health Service (ref: X06-0285 and 08/RPAH/218).
The interview included sections on the following: demo-
graphic characteristics, previous and current pregnancy char-
acteristics, antenatal care, physical health service utilization,
substance use history, injecting risk behaviour, exposure to
violence, and mental and physical functioning. Health status
was measured using the Short Form 12-item Health Survey
(SF-12) [10]. The SF-12 generates two summary scores
reflecting general physical and mental health functioning.
The Depression Anxiety Stress Scale short version (DASS21)
[11] was used to measure symptoms of depression, anxiety,
and stress. The DASS21 has good reliability and validity and
includes normative data for the Australian population. The
Opiate Treatment Index (OTI) [12] was used to measure
social functioning and the extent of substance use. The OTI
provides an estimate of substance use based on the last
three occasions of use. All other questions were derived
from previous research conducted by the National Drug and
Alcohol Research Centre (NDARC) (details can be provided
by the authors on request).
3. Statistical Analyses
The data were analysed using PASW version 18 [13]. t-tests
were used for continuous variables with means reported.
Odds ratios and 95% confidence intervals were reported for
nondichotomous categorical variables (OR, 95% CI) to de-
termine if diﬀerences existed between substance dependent
and comparison groups. There was nomissing data for either
sample.
4. Results
The results are based on interviews with 41 pregnant women
with a known history of substance dependence (i.e., sub-
stance dependent group), and a comparison group of 47
women attending the general antenatal clinic (i.e., compari-
son group). Twenty-eight (70%) women in the substance de-
pendent group were currently receiving substance use treat-
ment, the majority (71%) of whom were enrolled in opioid
pharmacotherapy (with a median duration of 11 months).
Table 1 displays the demographic and psychosocial char-
acteristics of the women.
4.1. Antenatal Care. The women in the substance-dependent
group were significantly more likely to present for their first
antenatal visit later in their pregnancy than the comparison
group (mean 14 versus 11 weeks pregnant, t63 = −3.02,
P < .05). While this is still within the hospital’s protocol for
low-risk pregnancies (i.e., by 20 weeks gestation), the women
in the substance dependent group would be considered high-
risk, and just over a third (34%) of the women presented
before 12 weeks, as per the hospital’s protocol for high-risk
pregnancies. A small proportion of women in the substance-
dependent and comparison group (11% versus 2%, resp.)
presented after 20 weeks gestation. The majority of the
women in the substance-dependent group (76%) experi-
enced some diﬃculty in accessing antenatal care (compared
to only 20% of the comparison group): 40% (versus 15%)
were unable to get an appointment; 24% (versus 0%) had
“too many other things going on;” 17% (versus 0%) had
insuﬃcient money; 15% (versus 2%) had no transport to
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Table 1: Demographic and psychosocial characteristics of pregnant substance dependent women and comparison group.
Substance dependent
group (n = 41)
Comparison
group (n = 47) Statistical comparison
Age (in years) mean (SD) 28.8 (5.3) 33.3 (4.2) t86 = 4.47∗∗
Years of completed schooling mean (SD) 10.3 (1.6) 11.9 (0.5) t46 = 6.12∗∗
% Currently married/de facto 46.3 93.6
OR 0.06 (95% CI
0.02–0.22)∗∗
% ATSI 26.8 0 N/A
% Unemployed 80.5 21.3 OR 15.3 (5.4–43.2)∗∗
% Currently homeless 12.2 2.1 not significant
% Exposed to violence in past year 24.4 8.5 OR 3.5 (1.00–12.08)∗
SF-12 Mental functioning score mean (SD) 43.2 (12.7) 52.5 (7.3) t60 = 4.1∗∗
SF-12 Physical functioning score mean (SD) 41.4 (9.4) 44.7 (7.8) not significant
DASS Depression score mean (SD) 9.9 (11.2) 4.4 (5.2) t55 = −2.9∗
DASS Anxiety score mean (SD) 6.7 (6.3) 3.0 (5.3) t77 = −2.9∗
DASS Stress score mean (SD) 12.5 (10.5) 7.7 (7.5) t69 = −2.4∗
∗P < .05.
∗∗P < .001.
get the hospital clinic; 7% (versus 2%) could not get time
oﬀ work; 12% (versus 0%) did not want others to know
of their pregnancy; 10% (versus 0%) reported not having
childcare available. None of the women reported diﬃculty
accessing antenatal care due to lack of a Medicare card.
All Australians are entitled to free ambulatory medical care
upon presentation of their Medicare card, but if misplaced,
procedures to access free care are more cumbersome.
4.2. Physical Health. Women in the substance-dependent
group were more than 3 times more likely to report at least
one obstetrical health complication during pregnancy (63%
versus 34%, OR 3.36, 95% CI 1.40–8.07, P < .05). Severe
vomiting and dehydration (54% versus 23%) was the most
commonly reported health problem by women in both
groups, followed by vaginal bleeding (27% versus 9%), prob-
lems with the placenta (12% versus 2%), and foetal growth
retardation (12% versus 0%). Blood clots, kidney/bladder
infection, and very high fever were each reported by 7%
of the women in the treatment sample for each condition.
Women in the comparison group were more likely to report
high blood pressure (6% versus 2%). One woman in the
substance-dependent group reported an incompetent cervix.
None of the women in either group experienced gestational
diabetes.
4.3. Obstetric Health. Most of the women (61%) in the sub-
stance-dependent group were in their third trimester of preg-
nancy at the time of being interviewed (mean 30 weeks;
range: 11–40 weeks), whereas the comparison group were
more likely to be in the second trimester when interviewed
(mean 27 weeks; range 12–39 weeks). Seventy-five percent of
the substance-dependent group and 57 percent of the com-
parison group had at least one prior pregnancy. Among these
women, the substance-dependent group were significantly
more likely to report a previous live birth (65% versus 43%,
OR 2.49, 95% CI 1.03–6.06, P < .05) and report a previous
termination (62% versus 19%, OR 6.94, 95% CI 2.59–18.57,
P < .001), compared to the comparison group. Additionally,
the women in the substance-dependent group were more
likely to report a previous premature delivery (14% versus
6%), a previous cesarean section (11% versus 6%), and a
previous miscarriage (46% versus 28%), compared to the
comparison group, but these diﬀerences were not statistically
significant. One woman in each group reported they had an
infant who died within the first year. None of the women in
either group reported a still birth.
4.4. Pregnancy Planning. While the majority of the women
in the comparison group (79%) reported “wanting to
become pregnant,” only 29% of the women in the substance-
dependent group reported the same feelings (i.e., 9 times
less likely (95% CI 3.39–23.81, P < .001). A substantial
proportion of women in the comparison group reported
they had not thought about becoming pregnant (49% versus
21%, OR 3.52, 95% CI 1.39–8.92, P < .05). Whilst 22%
of the women in the substance dependent group specifically
stated they had not wanted to become pregnant (compared
to 0% in the comparison group). Of those who had not
thought about being pregnant or did not want to become
pregnant (29 women in the substance-dependent group and
10 women in the comparison group), only 14% of the
substance-dependent group (versus 40% comparison group)
reported using birth control at the time of conception.
4.5. Mental Health. The substance-dependent group had
poor psychosocial functioning as evidenced by the low mean
scores on the SF-12. The SF-12 is standardised to have amean
of 50 and a standard deviation of 10; thus, the average scores
indicate that these women are more than half a standard
deviation below the population norm for mental functioning
and almost one standard deviation below the population
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Table 2: Lifetime and 1-month prevalence of substance use among substance-dependent women and comparison group.
Substance
dependent group
(n = 41)
Comparison group
(n = 47)
Statistical comparison
OR (95% CI)
ALCOHOL
% Ever used 95.0 97.9 not significant
% Used last month 22.5 48.9 0.30 (0.12–0.77)∗
Mean days used month (SD) 3.4 (2.9) 3.9 (2.3) not significant
NICOTINE
% Ever used 97.6 74.5 13.70 (1.70–111.11)∗
% Used last month 78.0 4.3 80.0 (16.19–395.37)∗∗
Mean days used month (SD) 27.9 (6.8) 20.0 (14.1) not significant
CANNABIS
% Ever used 95.1 83.0 not significant
% Used last month 34.1 0.0 N/A
Mean days used month (SD) 18.2 (12.6) 0 N/A
HEROIN
% Ever used 75.6 4.3 71.43 (14.29–333.33)∗∗
% Used last month 17.1 0.0 N/A
Mean days used month (SD) 5.3 (6.9) 0 N/A
% Ever injected 56.1 0.0 N/A
% Injected last month 12.2 0.0 N/A
AMPHETAMINE
% Ever used 80.0 46.8 4.55 (1.73–11.90)∗
% Used last month 2.5 0.0 N/A
Mean days used month (SD) 2.0 (0.3) 0 N/A
% Ever injected 47.5 0.0 N/A
% Injected last month 0.0 0.0 N/A
COCAINE
% Ever used 68.3 40.4 3.17 (1.32–7.63)∗
% Used last month 4.9 0.0 N/A
Mean days used month (SD) 1.5 (0.7) 0 N/A
% Ever injected 41.5 0.0 N/A
% Injected last month 0.0 0.0 N/A
BENZODIAZEPINE
% Ever used 75.6 14.9 17.86 (6.06–52.63)∗∗
% Used last month 12.2 0.0 N/A
Mean days used month (SD) 13.6 (15.0) 0 N/A
% Ever injected 7.3 0.0 N/A
% Injected last month 0.0 0.0 N/A
∗P < .05.
∗∗P < .001.
norm for physical functioning. While the comparison group
had a significantly higher SF-12 score for mental functioning,
their physical functioning score was fairly comparable to the
substance-dependent group. It is likely that the health eﬀects
of pregnancy account for below population norm scores on
the physical functioning subscale for this group.
The mean scores for the DASS subscales show the major-
ity of women in the substance dependent and comparison
groups scored in the normal/mild range for depression (81%
versus 92%, resp.), anxiety (73% versus 89%, resp.), and
stress (75% versus 94%, resp.). A higher proportion of
women in the substance-dependent group, compared to the
comparison reported high levels of distress (thus elevating
the mean score for the sample): 15% (versus 0%) of the
women were rated as severe/extremely severe for depression,
10% (versus 6%) as severe/extremely severe for stress, and
10% (versus 2%) as severe/extremely severe for anxiety.
4.6. Substance Use. Themean age at first use of any substance
was 14 years for the substance-dependent group (range: 9–
20 years) and 13 years for the comparison group (range: 9–
19 years). Alcohol was the drug first used by the majority
of women in both the substance-dependent and comparison
groups (46% versus 98%, resp.), followed by cannabis (37%
versus 2%, resp.), and heroin (12% versus 0, resp.). Table 2
shows the prevalence of lifetime and recent substance use.
The women in comparison group reported no illicit drug
use in the past month. Cannabis was themost prevalent illicit
drug used in the past month by women in the substance-
dependent group (34%). Among those women who used
cannabis in the preceding month, the mean number of days
used was 18, with most women using multiple times per
day. Just under one fifth (17%) of the women had used
heroin in the preceding month, on average once every five
to six days. Benzodiazepine use was reported by 12% of
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the substance dependent group; however, the majority of the
women reported one dose per day which possibly reflects
prescribed use. With regard to licit drug use, women in the
comparison group were significantly more likely to report
alcohol use in the preceding month (49% versus 23%), with
most women in both groups reporting just under 4 days of
alcohol use during this period. An examination of individual
OTI scores revealed no evidence of binge drinking in the
past month. Seventy-eight percent of the women in the
substance dependent group had smoked a cigarette in the
preceding month (compared with 4% of the comparison
group). While the women in the substance-dependent group
reported smoking more days in the past month, the women
in the comparison group reported smoking more cigarettes
per day (mean 13 compared to 10).
Twelve percent of the women in the substance-dependent
group reported injecting heroin in the month preceding the
interview, with the majority reporting this occurred once a
week or less (95%). Of the women who reported injecting in
the past month, half reported needle sharing on at least one
occasion. Fifty-five percent of the women in the substance-
dependent group had hepatitis C. The mean age at which
they were first diagnosed with the disease was 22 years
old. None of the women reported hepatitis B or HIV/AIDS
infection.
4.7. Exposure to Violence. Women in the substance-depend-
ent group were more than 3 times more likely to report
being the victims of violence in the preceding twelve months,
compared to the comparison group. Despite this, a small
proportion of women in the comparison group reported
being a victim of violence in the past year, but the context
was very diﬀerent to that of the substance-dependent group.
The majority of women in the substance-dependent group
reported the violence occurredmultiple times within the year
at home, and it was perpetrated by their partner. While in the
comparison group, the incidences of violence reported were
mostly isolated, occurring in the workplace; for example, the
violence was perpetrated by a mental health patient towards
a nurse.
5. Discussion
This study documents a broad spectrum of physical and psy-
chosocial concerns among pregnant women with a known
history of substance dependence attending a specialist ante-
natal clinic, and a comparison group of women attending the
general antenatal clinic, of a large public hospital in Sydney.
The findings indicate that while a comprehensive model of
care has been implemented, this may still be inadequate to
meet clinical needs of this group. The results suggest the
profile of pregnant women (in specialised antenatal care for
substance dependence) is one of severe disadvantage and
poor health.
Many of the current pregnancies were unplanned, and
there was low use of birth control practices among the
women. A number of women commented that they did not
think they could get pregnant. This may be related to the high
rate of menstrual dysfunction among opioid-dependent fe-
males [14, 15] and suggests that there is a need for education
regarding the importance of birth control even in the context
of absent or irregular menses. In addition, cost-eﬀective
strategies to increase the use of contraception in this pop-
ulation need to be developed and implemented. This is a
complex issue, as women with substance use problems may
find the daily adherence to an oral or barrier method of con-
traception diﬃcult, given their often chaotic lifestyle.
Women in the substance-dependent group reported
substantially higher rates of severe vomiting and dehydration
compared to the comparison group. This diﬀerence may in
part be explained by the fact that nausea and vomiting are
direct actions of opioid drugs. While individuals stabilised
onmethadone with an established tolerance typically will not
experience these adverse eﬀects, an increase in dose (which
may be required in pregnancy) can precipitate a recurrence
[16, 17]. The majority of the women evidenced normal men-
tal health as measured by the DASS21. This is somewhat sur-
prising, given the high prevalence of psychiatric comorbidity
consistently reported among substance use populations [18–
21] but may be a reflection of the level of care the women
received through this antenatal clinic. However, a proportion
of the women in this study continued to report severe levels
of psychological distress. This is of significant concern, given
that psychological distress is associated with an increased risk
for low birth weight and preterm delivery [2, 22] as well as
an increased risk for maternal depression in the postpartum
period [23].
Exposure to violence is also a significant concern for
a proportion of the women in this sample, especially as
partners were the predominant perpetrators of the violence
for women in the substance-dependent group, and many of
these women may continue in these relationships following
the birth. This has a number of implications for the well-
being of both mother and infant in the longer term, as
the risk for a range of adverse outcomes, such as child
maltreatment and homelessness, are strongly associated with
family violence [24, 25]. Additionally, physical violence has
been found to be an independent risk factor for low birth
weight infants, possibly mediated by the impact of mater-
nal stress on foetal development [26]. Studies examining
violence, psychological stress, and depression show there is
significant interplay between these factors, suggesting that
concurrent management of these issues is warranted [5].
Almost all the women in the substance-dependent group
were interviewed in their last trimester of pregnancy, and
most had been attending the specialist antenatal clinic since
early in their second trimester. The continued use of illicit
drugs within this context is disquieting and underscores the
chronic nature of substance dependence.
Whilst the proportion of women who had used heroin in
the past month was relatively low, most had used the drug
regularly and almost all had injected it. Whilst pregnancy is
commonly thought to be associated with positive changes
in substance use in the general population, it may not have
the same impetus among women with severe substance
dependence. Why is it that these rates of drug use are re-
ported among women attending a specialist antenatal clinic
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designed specifically for them? It is possible the women are
reticent to disclose ongoing drug use to clinic staﬀ for fear
of notification to child protection authorities. This suggests
that screening for substance use during pregnancy among
women already receiving drug treatment may need to be
reviewed. In particular, nicotine use has been associated with
an increased risk for use of other substances [27] and could
be seen as a flag for a more detailed inquiry of substance
use throughout the pregnancy. This could be coupled with
information and advice regarding the supportive role that
child protection agencies and health service providers can
have in ensuring the long-termwell-being of both the women
and their infants.
In addition, the substantially high rates of nicotine use
are of a concern considering the adverse health eﬀects which
are consistently identified for bothmother and foetus includ-
ing pregnancy complications and poor birth outcomes (e.g.,
placental abruption, low birthweight, neonatal death, and
preterm birth [28, 29]. Women in the substance-dependent
group were smoking on average 10 cigarettes per day (less
than the comparison group), indicating they may been aware
of such adverse eﬀects and have tried to cut down but find
it extremely diﬃcult to quit. The findings imply the depen-
dence severity of nicotine is severe, with research suggestive
that the addictive properties of nicotine are comparable
to other illicit drug types [30, 31]. In addition, a recent
Cochrane review suggests alternative interventions (i.e.,
providing incentives through use of vouchers or financial
rewards) should be considered [32]. This suggestion seems
particularly salient among at risk groups, as it is likely that the
high cost of nicotine-replacement therapies make them inac-
cessible to disadvantaged groups within the community.
Of concern is the finding that just under half of the
women in the comparison group reported alcohol use in
the past month, with the majority reporting alcohol use on
average once a week. Current Australian and international
guidelines recommend that no alcohol during pregnancy is
the safest option [33], as a threshold for negative eﬀects on
the neonate are yet to be determined. The results combined
with anecdotal reports from the women that they received
conflicting advice from doctors supports previous findings
that there is a lack of knowledge about the risks to the
foetus and uncertainty regarding safe levels of alcohol use
in pregnancy [34, 35]. More research is required to ease
uncertainty, and public health campaigns would assist in
educating women about the risks of alcohol use in pregnancy.
A number of limitations require mentioning. First,
this study relied on retrospective self-report. Reluctance
to answer sensitive questions such as substance use and
exposure to violence may have resulted in an underestimate
of these problems. Studies comparing urine toxicology and
self-report measures of substance use have shown that this
is likely for illicit but not licit substances [31]. Secondly,
the study is based on a conservative sample of pregnant
women who are engaged in health care and who consented to
being interviewed. The recruitment process was diﬃcult and
protracted (approximately 18 months). It is possible that the
more chaotic women declined to participate (possibly due to
fears that child protection services would become involved),
and therefore, the study findings are likely to be an under-
estimate of the extent of psychosocial and physical health
problems associated with substance dependence in preg-
nancy. Finally, the study utilised a sample of pregnant women
attending a specific substance use antenatal clinic in a large
inner metropolitan hospital; the results, therefore, may not
be applicable to all substance-dependent pregnant women.
All women in the substance-dependent group had a history
of problematic substance use, and it should be noted as a lim-
itation that not all women were currently receiving pharma-
cotherapy treatments. This may have influenced some of the
results related to mental health and antenatal care outcomes.
6. Conclusions
These limitations notwithstanding, the findings of the
present study highlight the need to look beyond the neonatal
impact of substance use during pregnancy and consider both
neonatal and maternal indices of well-being. Maternal and
infant health is interdependent; in order to achieve the best
outcomes for infants, improvements in antenatal care are
required to address the complexity of physical and psychoso-
cial problems in the mother. In particular, there is a need
to further develop comprehensive and integrated strategies
that address (1) the complex interplay between interpersonal
violence, psychological stress, low mood, and substance use,
(2) the continued use of substances commonly perceived
by substance-dependent persons to be less problematic (i.e.,
nicotine and cannabis), and (3) the poor understanding of
female reproductive health and limited use of contraception.
These health concerns are readily treatable. What is lacking
is a coordinated approach that targets multiple problems
within a single intervention. More specifically, the women
reported diﬃculties in accessing health care suggesting that
a more coordinated and flexible model of care may be
warranted to both engage and maintain an eﬀective line of
care and treatment.
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